Wednesday

21st Nov 2018

EU drugs agency working with patient groups bankrolled by big pharma

  • Transparency watchdogs say the EMA is not doing enough to avoid the appearance of conflict of interest (Photo: www.freeimages.co.uk)

European patients' groups, set up to represent the interests of the subjects of medical procedures in their dealings with healthcare systems, insurance firms and drug companies are in many cases bankrolled by pharmaceutical firms, according to a new report.

Complicating the situation, many such groups working with and on the board of the European Medicines Agency - the very EU agency charged with evaluation of medicines in the bloc.

Read and decide

Join EUobserver today

Support quality EU news

Get instant access to all articles — and 18 year's of archives. 30 days free trial.

... or join as a group

A fresh report from transparency watchdog Corporate Europe Observatory accuses the EMA of mis-administrating conflict of interest guidelines allowing individuals and groups to falsely say that they are not sponsored by the pharmaceutical industry.

The document makes four accusations of conflict of interest non-disclosure.

The report notes that the representative of the European Federation of Neurological Associations (EFNA), a patient group that also sits on the EMA's management board, failed to disclose the corporate funding of EFNA on her EMA conflict of interest statement even though 91 percent of the group's total income stems from corporate sponsors, including GlaxoSmithKline, Novartis and Solvay.

A second group that also maintains a representative on the EMA board, the European Patients Forum (EPF), receives hundreds of thousands of euros every year from industry, including Astrazeneca, Novartis and Pfizer.

Additionally the vice-chair of the Committee for Orphan Medicinal Products (COMP), a working group of the the EMA, represents Eurordis, the rare diseases patients' umbrella organisation, which receives 23 percent of its income from pharmaceutical companies. But the vice-chair also does not declare this interest in the mandatory annual disclosure statement.

Lastly, the European AIDS Treatment Group (EATG) representative on the EMA's Paediatric Committee (PDCO) also made no disclosures despite receiving more than 80 percent of its funding from corporate sponsors such as Pfizer and Roche.

Moreover, says the report, only six of 22 the patient groups - who engage in lobbying of European institutions - that work under with the EMA have taken it upon themselves to register with the European Commission's lobby register.

"In fact, more than half of the patient groups in EMA committees are sponsored by industry," the report's author, Jens Clausen, told EUobserver.

"This widespread practice of accepting funding from business can have serious implications. There is a fundamental risk that the patient group does not actually represent patient interests but instead puts forward the views of industry."

" Disclosure of funding sources is key if society is to be able to prevent corporate capture of public health policies."

The EMA for its part concedes that there is a problem, but with the conflict-of-interest declaration forms, which spokesman Martin Harvey concedes are not sufficiently clear.

"The declaration of interest forms we give aren't very helpful. Neither of the two individuals on the board are employed by the patient groups, and that is what the form asks."

"There's nothing sinister going on. They thought they were being truthful on the forms. We've had similar complaints on our end about the confusion of the forms, so we are considering changing them to solve this problem."

Mr Harvey said that such representatives are nominated by the European Commission and the European Parliament, suggesting that if a conflict exists, it should be spotted by the Brussels officials that review the candidates: "They send us approved people and we have to take them."

He added that patient groups at the national level depend for the bulk of the funding on the money people leave in their wills, often people who have been afflicted by the given illness.

"But at the European level, no one wants to leave an EU patient group money. There's no emotional connection, there's no link with your family," he said. "So if they don't take money from industry, where will they take it from?"

The EMA accepts that patient groups take money from pharmaceutical companies, "but we mitigate this by requiring that they be scrupulously transparent and that the funding comes from a diversity of sources."

He also said that the individuals concerned by the report were "hard-working volunteers who commit an awful lot of time to these causes and were quite shocked by the accusations."

EU health commissioner John Dalli in his hearing in the European Parliament before being confirmed promised to reconsider the issue of the funding of patient groups to prevent conflict of interest.

Mr Harvey said that in the absence of money from big pharma, the only way to completely avoid conflict of interest was to have European patient groups publicly funded.

"Although then you have the situation of the EU paying patient groups to lobby itself."

Opinion

Challenges for new Franco-German eurozone plan

With both Macron and Merkel losing support domestically, it is questionable whether their plans will succeed. Even more so, given the opposition by the Hanseatic states, the upcoming European elections and Italy's political hooliganism.

Opinion

EU parliament vote strengthens whistleblower protection

We must not undervalue what a massive step the European Parliament vote represents. The hard work has paid off. We can take a moment to celebrate, but the hard work begins again for finalising strong protection for European whistleblowers.

Deutsche Bank dragged into Danish bank scandal

Deutsche Bank, Germany's top lender, handled about €130bn of the "suspicious" money in the Danske Bank affair, new revelations show, as whistleblower testifies to MEPs.

New EU human rights sanctions to focus on Africa

A new EU sanctions regime for human rights abusers ought to focus on the kinds of crimes most readily associated with African conflicts, the Dutch foreign minister has indicated.

Exclusive

EU parliament to renege on transparency promises

Internal legal European parliament documents circulated Tuesday, and seen by EUobserver, rule it illegal to force MEPs to meet only registered lobbyists. The opinion will likely render a larger effort to create a mandatory register for lobbyists null and void.

News in Brief

  1. MEPs delay vote on greater transparency
  2. Interpol rejects Russian candidate after outcry
  3. Investors seek compensation for Danske Bank losses
  4. Analysis: one-in-four Europeans vote populist
  5. Italy moves to seize Aquarius for illegal waste disposal
  6. EU parliament approves Italian to check European banks
  7. EU agrees tightening rules on foreign strategic investment
  8. Soros' foundation demands apology from Facebook

Opinion

EU parliament vote strengthens whistleblower protection

We must not undervalue what a massive step the European Parliament vote represents. The hard work has paid off. We can take a moment to celebrate, but the hard work begins again for finalising strong protection for European whistleblowers.

Stakeholders' Highlights

  1. NORDIC COUNCIL OF MINISTERSNordic Region has chance to become world leader when it comes to start-ups
  2. NORDIC COUNCIL OF MINISTERSTheresa May: “We will not be turning our backs on the Nordic region”
  3. International Partnership for Human RightsOpen letter to Emmanuel Macron ahead of Uzbek president's visit
  4. International Partnership for Human RightsRaising key human rights concerns during visit of Turkmenistan's foreign minister
  5. NORDIC COUNCIL OF MINISTERSState of the Nordic Region presented in Brussels
  6. NORDIC COUNCIL OF MINISTERSThe vital bioeconomy. New issue of “Sustainable Growth the Nordic Way” out now
  7. NORDIC COUNCIL OF MINISTERSThe Nordic gender effect goes international
  8. NORDIC COUNCIL OF MINISTERSPaula Lehtomaki from Finland elected as the Council's first female Secretary General
  9. NORDIC COUNCIL OF MINISTERSNordic design sets the stage at COP24, running a competition for sustainable chairs.
  10. Counter BalanceIn Kenya, a motorway funded by the European Investment Bank runs over roadside dwellers
  11. ACCACompany Law Package: Making the Best of Digital and Cross Border Mobility,
  12. International Partnership for Human RightsCivil Society Worried About Shortcomings in EU-Kyrgyzstan Human Rights Dialogue

Latest News

  1. Challenges for new Franco-German eurozone plan
  2. EU parliament vote strengthens whistleblower protection
  3. Deutsche Bank dragged into Danish bank scandal
  4. New EU human rights sanctions to focus on Africa
  5. Boycott threats mount on eve of Interpol election
  6. EU parliament to renege on transparency promises
  7. Cyprus and Greece to create EU spy academy
  8. MEPs likely to delay vote on greater transparency

Stakeholders' Highlights

  1. UNESDAThe European Soft Drinks Industry Supports over 1.7 Million Jobs
  2. Mission of China to the EUJointly Building Belt and Road Initiative Leads to a Better Future for All
  3. International Partnership for Human RightsCivil society asks PACE to appoint Rapporteur to probe issue of political prisoners in Azerbaijan
  4. ACCASocial Mobility – How Can We Increase Opportunities Through Training and Education?
  5. Nordic Council of MinistersEnergy Solutions for a Greener Tomorrow
  6. UNICEFWhat Kind of Europe Do Children Want? Unicef & Eurochild Launch Survey on the Europe Kids Want
  7. Nordic Council of MinistersNordic Countries Take a Stand for Climate-Smart Energy Solutions
  8. Mission of China to the EUChina: Work Together for a Better Globalisation
  9. Nordic Council of MinistersNordics Could Be First Carbon-Negative Region in World
  10. European Federation of Allergy and AirwaysLife Is Possible for Patients with Severe Asthma
  11. PKEE - Polish Energy AssociationCommon-Sense Approach Needed for EU Energy Reform
  12. Nordic Council of MinistersNordic Region to Lead in Developing and Rolling Out 5G Network

Join EUobserver

Support quality EU news

Join us